Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage

Documenti analoghi

• Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
  di: Andrea M. Kuczynski, et al.
  Pubblicazione: (2025)
• Cardiovascular risk and triptan usage among patients with migraine
  di: Ido Peles, et al.
  Pubblicazione: (2025)
• Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
  di: Seonyoung Kang, et al.
  Pubblicazione: (2024)
• Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
  di: Graham A. McLeod, et al.
  Pubblicazione: (2025)
• Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
  di: Chia‐Chun Chiang, et al.
  Pubblicazione: (2024)